SARS-CoV-2 in inflammatory bowel disease population: Antibodies, disease and correlation with therapy

Table 2 Survey responses of 103 inflammatory bowel disease patients

Survey answers
Close contacts with positive patients (n, %)		Yes	17, 16.5
		No	85, 82.5
		Nd	1, 1
Tested for swab (n, %)		Yes	13, 12.5	Positive	1, 1
				Negative	12, 11.5
		No	90, 87.5
Symptoms (n, %)	No symptoms		49, 47.5
	Mild	Cough	19, 18.4
		Changes in taste/smell	6, 5.8
		Muscle and joint pain	12, 11.6
		Asthenia	11, 10.6
		Fever	18, 17.4
		GI symptoms	23, 22.3
	Severe	Mild dyspnea	4, 3.8
		Pneumonia	1, 0.9
Total number of patients (n)						103

GI: Gastrointestinal; Nd: Not determined.